United States
- United States
Hagens Berman: Kenvue, Inc. (KVUE) Accused of Not Disclosing Known Commercial Risks to Cold Medicine Drugs Firm Encourages Kenvue (KVUE) Investors with Substantial Losses to Contact its Attorneys
SAN FRANCISCO, Oct. 26, 2023 (GLOBE NEWSWIRE) — Hagens Berman urges Kenvue, Inc. (NYSE: KVUE) investors who invested in Kenvue shares pursuant or traceable to Kenvue’s May 2023 initial public offering and who suffered substantial…
Read More »